Author:
Spacova Irina,Ahannach Sarah,Breynaert Annelies,Erreygers Isabel,Wittouck Stijn,Bron Peter A.,Van Beeck Wannes,Eilers Tom,Alloul Abbas,Blansaer Naïm,Vlaeminck Siegfried E.,Hermans Nina,Lebeer Sarah
Abstract
Riboflavin-producing lactic acid bacteria represent a promising and cost-effective strategy for food biofortification, but production levels are typically insufficient to support daily human requirements. In this study, we describe the novel human isolate Limosilactobacillus reuteri AMBV339 as a strong food biofortification candidate. This strain shows a high natural riboflavin (vitamin B2) overproduction of 18.36 μg/ml, biomass production up to 6 × 1010 colony-forming units/ml (in the typical range of model lactobacilli), and pH-lowering capacities to a pH as low as 4.03 in common plant-based (coconut, soy, and oat) and cow milk beverages when cultured up to 72 h at 37°C. These properties were especially pronounced in coconut beverage and butter milk fermentations, and were sustained in co-culture with the model starter Streptococcus thermophilus. Furthermore, L. reuteri AMBV339 grown in laboratory media or in a coconut beverage survived in gastric juice and in a simulated gastrointestinal dialysis model with colon phase (GIDM-colon system) inoculated with fecal material from a healthy volunteer. Passive transport of L. reuteri AMBV339-produced riboflavin occurred in the small intestinal and colon stage of the GIDM system, and active transport via intestinal epithelial Caco-2 monolayers was also demonstrated. L. reuteri AMBV339 did not cause fecal microbiome perturbations in the GIDM-colon system and inhibited enteric bacterial pathogens in vitro. Taken together, our data suggests that L. reuteri AMBV339 represents a promising candidate to provide riboflavin fortification of plant-based and dairy foods, and has a high application potential in the human gastrointestinal tract.
Funder
Fonds Wetenschappelijk Onderzoek
Universiteit Antwerpen
European Research Council
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Food Science
Reference69 articles.
1. Scientific Opinion on the substantiation of health claims related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism (ID 29, 35, 36, 42), contribution to normal metabolism of iron (ID 30, 37), maintenance of normal skin and m.;EFSA J.,2010
2. Global concerns with B vitamin statuses: biofortification, fortification, hidden hunger, interactions, and toxicity.;Titcomb;Compr Rev Food Sci Food Safe.,2019
3. Dietary reference values for riboflavin.;EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), Turck;EFSA J.,2017
4. Dietary intake patterns among lactating and non-lactating women of reproductive age in rural Zambia.;Kaliwile;Nutrients.,2019
5. Mild riboflavin deficiency is highly prevalent in school-age children but does not increase risk for anaemia in Côte d’Ivoire.;Rohner;Br J Nutr.,2007
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献